Skip to Main Content

Paper Details

LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancer.
Commun Biol
12
2021
Author NameAffiliation
Yidong ChenMays Cancer Center, University of Texas Health San Antonio
Yidong ChenGreehey Children's Cancer Research Institute, University of Texas Health San Antonio
Ganesh V RajUniversity of Texas Southwestern Medical Center at Dallas
  • 1 - 3

Datasets

Release 1.2